荣昌生物独立董事马兰辞职

财中社11-14

财中社11月14日电荣昌生物（688331/09995）发布关于独立董事辞职的公告。独立董事马兰因根据中国科学院院士兼职管理的相关规定，申请辞去公司第二届董事会独立董事及相关委员会职务。辞职后，马兰将不再担任公司任何职务。由于马兰的辞职将导致公司独立董事人数少于董事会成员的三分之一，其辞职报告将在新的独立董事到任之日或独立董事人数恢复到不少于董事会人数的三分之一时生效。在此之前，马兰将继续履行职责...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2483684277?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-14 16:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2483684277","market":"hk","top_or_hot":-1,"title":"荣昌生物独立董事马兰辞职","media":"财中社","content":"<div>\n<p>财中社11月14日电荣昌生物（688331/09995）发布关于独立董事辞职的公告。独立董事马兰因根据中国科学院院士兼职管理的相关规定，申请辞去公司第二届董事会独立董事及相关委员会职务。辞职后，马兰将不再担任公司任何职务。由于马兰的辞职将导致公司独立董事人数少于董事会成员的三分之一，其辞职报告将在新的独立董事到任之日或独立董事人数恢复到不少于董事会人数的三分之一时生效。在此之前，马兰将继续履行职责...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114163408a236d226&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>荣昌生物独立董事马兰辞职</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n荣昌生物独立董事马兰辞职\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-14 16:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114163408a236d226&s=b><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>财中社11月14日电荣昌生物（688331/09995）发布关于独立董事辞职的公告。独立董事马兰因根据中国科学院院士兼职管理的相关规定，申请辞去公司第二届董事会独立董事及相关委员会职务。辞职后，马兰将不再担任公司任何职务。由于马兰的辞职将导致公司独立董事人数少于董事会成员的三分之一，其辞职报告将在新的独立董事到任之日或独立董事人数恢复到不少于董事会人数的三分之一时生效。在此之前，马兰将继续履行职责...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114163408a236d226&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1969619763.USD","symbol_name":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114163408a236d226&s=b","article_id":"2483684277","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114163408a236d226&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2483684277","pubTimestamp":1731573120,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"财中社11月14日电荣昌生物（688331/09995）发布关于独立董事辞职的公告。独立董事马兰因根据中国科学院院士兼职管理的相关规定，申请辞去公司第二届董事会独立董事及相关委员会职务。辞职后，马兰将不再担任公司任何职务。由于马兰的辞职将导致公司独立董事人数少于董事会成员的三分之一，其辞职报告将在新的独立董事到任之日或独立董事人数恢复到不少于董事会人数的三分之一时生效。在此之前，马兰将继续履行职责。公司将尽快完成新任独立董事的补选工作。2024年前三季度，荣昌生物实现收入12.09亿元，归母净利润-10.71亿元。（文章来源：财中社）","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688331":"荣昌生物","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","BK1161":"生物科技","BK1574":"生物医药B类股","09995":"荣昌生物","BK1583":"高瓴概念","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD"},"translate_title":"Rongchang Biotech independent director Ma Lan resigned","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688331":0.9,"09995":1},"content_text":"财中社11月14日电荣昌生物（688331/09995）发布关于独立董事辞职的公告。独立董事马兰因根据中国科学院院士兼职管理的相关规定，申请辞去公司第二届董事会独立董事及相关委员会职务。辞职后，马兰将不再担任公司任何职务。由于马兰的辞职将导致公司独立董事人数少于董事会成员的三分之一，其辞职报告将在新的独立董事到任之日或独立董事人数恢复到不少于董事会人数的三分之一时生效。在此之前，马兰将继续履行职责。公司将尽快完成新任独立董事的补选工作。2024年前三季度，荣昌生物实现收入12.09亿元，归母净利润-10.71亿元。（文章来源：财中社）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483684277"}